Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chengdu Baiteng Pharmaceutical Technology (Baiteng Pharma) is a specialized Contract Research Organization (CRO) and CDMO focused on pharmaceutical solid-state research and crystallization process development. The company provides essential services for small molecule drug development, including polymorph screening, salt and cocrystal selection, and amorphous solid dispersion optimization. By leveraging advanced analytical tools and crystallization engineering, Baiteng Pharma helps clients improve the solubility, stability, and bioavailability of challenging drug candidates. Based in Chengdu's Tianfu International Bio-town, the firm supports a global clientele ranging from biotech startups to large pharmaceutical corporations. Their technical expertise extends from early-stage pre-formulation to the scale-up of crystallization processes for commercial manufacturing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 成都柏腾医药科技.